EnglishFrenchGermanItalianPortugueseRussianSpanish

Is It Time to Change Your Supply Chain Solution Provider?

Is your supply chain solution provider dropping the ball? Is it doing everything it can to help you meet global compliance like EU FMD, U.S. DSCSA, and Russia Chestny ZNAK? What about serialization, traceability, environmental monitoring, safety, data analytics, and your other key needs?

If you operate a pharma supply chain in the EU, Russia, the United States — anywhere — think about this:

An effective supply chain is like an effective athlete. It’s fast. It works toward goals. It always plays by the rules. It uses data to innovate and improve performance. It communicates with its team members. It focuses on excellence 24/7. It wins the game.

But to optimize its potential, it needs an effective coach. That coach is your solution provider, and rfxcel wants you to know that we have a 17-year track record of serialization, traceability, and supply chain excellence in the pharma industry. So, if you’re thinking it’s time for a change because your current solution provider isn’t getting you the wins you want, we want you to take a look at us.

Here’s why.

You’ll be fast and work toward goals

When you work with rfxcel, you’re fast right out of the gate and focused on your business goals. Our preconfigured and pre-validated solutions simplify the implementation process, meaning you’ll have a fully validated production solution in under 30 days. We listen to what your goals are and configure your solutions based on your guidance. You review and approve the implementation. Plus, our solutions are available in a variety of languages, which speeds implementation and boosts ease of use because people can work in their native language.

You’ll always “play by the rules” — you’ll always be compliant

rfxcel has the most comprehensive compliance reporting solution for your regulatory requirements. With us, you never have to worry if you’re compliant, no matter where you’re doing business. To illustrate, consider what we do for our pharmaceutical clients:

  • We deliver iron-clad global compliance: EU Falsified Medicines Directive (FMD); U.S. Drug Supply Chain Security Act (DSCSA); Russia’s National Track and Trace Digital System (Chestny ZNAK); India Drugs Authentication and Verification Application (DAVA); plus all regulations in China, South Korea, Brazil, Saudi Arabia, Turkey, and more.
  • We’ve sponsored pilots with U.S. Food and Drug Administration and the Brazilian Health Regulatory Agency (ANVISA)
  • We’ve processed more than 3 billion transactions and serial numbers.
  • The Top 6 pharma manufacturers in India have selected us as their solution provider.

A little more about Russia Chestny ZNAK

rfxcel is the leader in Russian compliance. We’ve been prepared for the country’s strict regulations since 2018, a year before they began rolling out. We’re one of few providers with in-country implementations. Over the last year, we tripled our workforce in Russia. That Moscow-based team provides our customers, which include major global consumer goods and pharmaceutical companies, the quickest time to market while fully automating their compliance reporting and assuring ongoing compliance. So, if you want to do business in Russia, rfxcel is your best choice for total supply chain compliance, optimization, and support.

You’ll use data to improve performance and innovate

Our full-stack rfxcel Traceability System software platform is one solution for your entire supply chain, enabling comprehensive serialization capabilities, true end-to-end traceability, compliance reporting, Internet of Things (IoT)-enabled environmental monitoring, and analytics from anywhere in the world. It can comprise up to eight discrete solutions that work in concert to harmonize, optimize, automate, and monitor virtually every aspect of your operations.

In other words, you will have around-the-clock access to rich, actionable data about everything in your supply chain, right down to the unit level. This is data you can use to improve performance, innovate your operations, and engage with consumers. Furthermore, our solutions support all industry and customized data formats, and we offer secured connections to exchange and manage/transform data.

You’ll connect and integrate with all your trading partners

With rfxcel, you’ll never be out of touch with your trading partners, no matter where they’re located. Thousands of companies are already connected to our network, which means almost instantaneous integration and communication across common trading partners. Our systems enable secure connections to exchange information, so your communications are always safeguarded. Most important, we have more than 70 data verifications that prevent bad data from entering your system. No garbage in means no garbage out.

You’ll get rfxcel’s world-class service and 24/7 support

Our industry-leading service doesn’t end after you’ve signed your contract and your system is implemented. Customer satisfaction is our No. 1 priority. We want you to be happy with our service, support, and products at all times.

Final thoughts

rfxcel is the coach you need to achieve peak supply chain performance. If your solution provider isn’t operating at this level, it’s probably time to think about switching teams. We deliver from one end of your supply chain to the other, whether it’s laboratory to patient, farm to table, or factory to retailer to point of purchase. We will help you meet compliance requirements and make your partners and customers happy. If your current provider isn’t delivering what you need, you need to contact us today.

COVID-19 (Coronavirus) and the Global Supply Chain: 5 Things to Know

COVID-19 has affected a wide array of industries and their supply chains but companies are doing as much as they can to help get these supply chains up and running again while also ensuring the safety of their workers. More hygiene measures, like wearing an N95 Respirator and carrying hand sanitizer, are being enforced to ensure no spread of the virus occurs while workers rush to bring back the supply of goods. No one knows how long COVID-19 will affect the global supply chain which is why it’s so important to work overtime ensuring things can get back to normality as soon as possible. A February 7 article in Forbes reported that 421 global companies, including 394 based in the United States, had discussed the COVID-19 outbreak in China during calls about first-quarter earnings. Their conclusion? The virus could have a negative impact on financial performance for that timeframe.

rfxcel is monitoring news about COVID-19. Below, we summarize five of the most recent developments. As we all know, the situation is changing every day – as do the key takeaways about how the virus is affecting global supply chains – so these are snapshots, not analyses, predictions, or conclusions.

We’ll continue following the situation, so check back often for updates.

1. Monday, Feb. 24: Potential U.S. Supply Chain Disruptions as More COVID-19 Cases Reported in China, Japan, and South Korea

China, Japan, and South Korea are major U.S. trading partners. Combined, these countries accounted for more than 25% of total American imports in 2019. Let’s break down the numbers from the U.S. Census Bureau to get an idea of the potential impacts on U.S. supply chains if factories in these countries were shut down for long periods.

China: No. 3 in total trade value in 2019
    • From 2018 to 2019, China’s trade with the United States fell 15.15 percent, from $654.36 billion to $555.25 billion.
    • In 2019, exports totaled $106.63 billion and imports totaled $448.62 billion (deficit of $342 billion).
    • Top 10 exports: civilian aircraft, parts; computer chips; soybeans; motor vehicles for transporting people; machinery, parts for semiconductor manufacturing; medical instruments for surgeons, dentists, vets; oil; plasma, vaccines, blood; medical equipment for physicals; medicines in individual dosage
    • Top 10 imports: cell phones, related equipment; computers; toys, children’s bicycles, games; TVs, computer monitors; motor vehicle parts; furniture, parts; seats, excluding barber, dental; electric water, space, soil heaters; lamp and lighting parts; computer parts
Japan: No. 4 in total trade value in 2019
    • Trade totaled $218.29 billion. Exports totaled $74.65 billion and imports totaled $143.64 billion (deficit of $68.98 billion).
    • Top 10 exports: civilian aircraft, parts; petroleum gases, other gaseous hydrocarbons; medical instruments for surgeons, dentists, vets; medicines in individual dosages; corn; machinery, parts for semiconductor manufacturing; pork meat, fresh, frozen or chilled; coal, briquettes; plasma, vaccines, blood; oil
    • Top 10 imports: motor vehicles for transporting people; motor vehicle parts; machinery, parts for semiconductor manufacturing; self-propelled heavy construction machinery; defense-related aircraft, parts; printers, all types, parts; value added to a returned import; medicines in individual dosages; motor vehicle engines; aircraft engines, engine parts
South Korea: No. 6 in total trade value in 2019
    • Trade totaled $134.41 billion. Exports totaled $56.9 billion and imports totaled $77.51 billion (deficit of $20.61 billion).
    • Top 10 exports: oil; machinery, parts for semiconductor manufacturing; computer chips; petroleum gases, other gaseous hydrocarbons; civilian aircraft, parts; motor vehicles for transporting people; frozen beef; medical instruments for surgeons, dentists, vets; gasoline, other fuels; acyclic alcohols
    • Top 10 imports: motor vehicles for transporting people; motor vehicle parts; gasoline, other fuels; computer parts; cell phones, related equipment; computer chips; plasma, vaccines, blood; unrecorded media for audio; rubber tires; refrigerators, freezers

2. Monday, Feb. 24: Shanghai introduces measures to help companies resume production and mitigate impact of COVID-19 outbreak

Local authorities in Shanghai’s Pudong New Area have introduced rent reduction, rent exemption, and other policies to help companies affected by the virus. The Pudong New Area is home to the Lujiazui Finance and Trade Zone and the Shanghai Stock Exchange, as well as the Port of Shanghai, the Shanghai Pudong International Airport, and the Zhangjiang Hi-Tech Park.

The Pudong New Area State-owned Assets Supervision and Administration Commission said more than 1 billion yuan (approximately $142 million) in rent reduction and exemption would benefit about 8,000 companies in the industry, retail, commerce, and technical services sectors.

According to officials, 66 percent of industrial enterprises, 93 percent of software information service companies, and more than 85 percent of foreign trade enterprises have resumed work in this key economic area.

In the nearby Lingang Special Area of China (Shanghai) Pilot Free Trade Zone, 971 companies have resumed operation and more than 40,000 employees have returned to work. Key sectors here include integrated circuits, artificial intelligence, biomedicine, aerospace, and new energy vehicles.

3. Friday, Feb. 21: Chinese President Xi Jinping says manufacturing supply chains should get help to resume output

At the meeting of the Communist Party Politburo on February 21, the Chinese president said the country must work to both contain the spread of COVID-19 and ensure that industry can resume output and meet economic targets. These comments came as businesses question Chinese suppliers’ ability to meet demand and consider finding other places to source materials.

“Priority should be given to ensure leading companies that are important in the global supply chain restore production and supply, maintaining the stability of the supply chain,” he said to the 25-member Politburo. “It is necessary to help key export enterprises resume work and production as soon as possible.”

4. Monday, Feb. 17: China has issued 1,600+ “force majeure certificates” to protect companies from legal damages arising from the COVID-19 outbreak

The China Council for the Promotion of International Trade (CCPIT) has issued 1,615 force majeure certificates to companies in more than 30 sectors, covering a total contract value of 109.9 billion yuan (approximately $15.7 billion).

Furthermore, China’s Ministry of Commerce has instructed six trade associations in the healthcare, textile, machinery, mining and other sectors to help with legal counseling and applying for the certificates.

A certificate protects a company that does not perform or only partially performs contractual duties by proving it is being affected by circumstances that are beyond its control. The CCPIT says its certificates are recognized by governments, customs organizations, trade associations ,and enterprises in more than 200 countries and regions.

5. Tuesday, Feb. 11: Dun and Bradstreet release white paper about COVID-19’s effect on global business

Here’s what the commercial data and analytics company estimates:

    • Approximately 90% of all active businesses in China are in the regions affected by COVID-19.
    • At least 51,000 companies around the world have one or more direct or Tier 1 suppliers in the affected region; 163 of these are Fortune 1000 companies.
    • At least 5 million companies have one or more Tier 2 suppliers in the affected region; 938 of these are Fortune 1000 companies.
    • Currently, 49,000 businesses in the affected region are branches or subsidiaries of companies headquartered outside China. Nearly half of these are based in Hong Kong, 19% are in the United States, 12% in Japan, and 5% in Germany. Other countries include the United Kingdom (including the Virgin Islands), the Cayman Islands, the Netherlands, Switzerland, and France.

 

Major Deadline Coming for the Footwear Industry in Russia’s Chestny ZNAK Track and Trace System

Note: On February 29, 2020, Russia changed key deadlines for footwear. Read about the new dates here.

 

March is a big month for footwear companies doing business in Russia. The next major deadline for Russia’s National Track and Trace Digital System, known as Chestny ZNAK, is March 1. If you’re selling footwear in Russia, here’s everything you need to know about the regulations.

Some background on Chestny ZNAK

Russia’s Federal Law No. 425-FZ mandates that companies must connect and comply with Chestny ZNAK, which is operated by the Center for Research in Perspective Technologies (CRPT). Ratified on December 29, 2017, the complex regulations will affect virtually every industry, from footwear and pharmaceuticals to tires and tobacco.

The goal of Chestny ZNAK is to protect consumers by keeping fake and substandard products out of the market. Hallmarks include 2D barcodes, serialization, crypto codes, and secure reporting and records management. Companies that are not fully compliant risk exclusion from lucrative Russian markets. Deadlines vary by industry, but Russia aims to have the total supply chain transformation completed by 2024.

Let’s do a quick overview of Chestny ZNAK for the footwear industry, what’s happened so far in 2020, and what’s in store for March.

Chestny ZNAK 101 for footwear

Manufacturers, importers, distributors, wholesalers, and retailers had to begin labeling their products with 2D Data Matrix codes beginning July 1, 2019. The CRPT provides the codes to these supply chain stakeholders, who must be registered in the Chestny ZNAK system.

Each code has an ID code that determines a product’s position in the track and trace system and in the unified catalogue of goods. A code must contain ten data points, including a Global Trade Item Number (GTIN), a tax identification number, the brand name, and the materials used to make the shoes.

Each Data Matrix code must have a verification code — a crypto “tail” or crypto code. The CRPT also generates the crypto codes, which are essentially a string of unique numbers and letters. We’ve been following news about the Chestny ZNAK crypto codes. Check out our last major update here. For recent news about other regulations and industries, see our story here.

Footwear and Chestny ZNAK: What’s happened so far in 2020 and what’s coming in March

As of February 1, 2020, actors in the footwear supply chain were expected to have obtained all the equipment needed to receive, print, affix, and test the 2D Data Matrix codes and crypto codes. This includes a special device called an issue registrar, through which the CRPT sends the codes. Other gear includes barcode scanners, printers, and cash registers. Manufacturers, importers, distributors, wholesalers, and retailers were also expected to have mastered the new system.

March 1 is the next big deadline for the footwear industry. Here are the key points:

  • Production and import of unlabeled shoes is prohibited.
  • Wholesale and retail sale of unlabeled footwear is prohibited.
  • Transfer of information about production, importation, and wholesale and retail sales to Chestny ZNAK becomes mandatory.
  • Note: Unlabeled footwear purchased before March 1 may be imported until April 1.
  • Note: Companies may label shoes made or acquired before March 1 until May 1, but only if they can document the date of manufacture or purchase.

Final thoughts

rfxcel is the undisputed leader in Russia compliance. We’ve prepared for Chestny ZNAK since 2018. We’re one of the few providers with active implementations in the country. We’ve tripled our workforce in Russia over the last year. Our team in Moscow provides our clients, which include major global consumer goods and pharmaceutical companies, the quickest time to market while fully automating their compliance reporting.

No matter how far along you are in your preparations to meet Chestny ZNAK requirements, we are who you need to talk to — even if you’re already working with another provider. Our powerful software ensures companies in any industry will remain compliant with Russia’s complex regulations while mastering their supply chains with end-to-end traceability and rich, actionable data mined right down to the unit level.

Email us today at russia@rfxcel.com to schedule a conversation with one of our supply chain experts in Moscow. We think you’ll be impressed when you learn more about our capabilities in Russia.

And be sure to read “Russia 2020: A Guide to Consumer Goods Supply Chain Compliance,” an easy-to-understand white paper that explains the fundamentals of the Russian legislation and puts it all in context. If you’re interested in what’s in store for pharmaceuticals in Russia, check out our white paper about that industry.

Join rfxcel at the HDA 2020 Distribution Management Conference and Expo in San Diego Next Month!

rfxcel will be at the Healthcare Distribution Alliance’s (HDA) 2020 Distribution Management Conference and Expo March 8-11 at the Marriott Marquis San Diego Marina (in San Diego, of course). We’re an official sponsor, and invite you to stop by Booth #103 to meet our team and learn the latest from the industry’s leader in supply chain traceability, environmental monitoring, and analytics!

We’re especially excited to talk about the Drug Supply Chain Security Act (DSCSA) Saleable Returns Verification requirement and the solution to meet it: the Verification Router Service (VRS). rfxcel and Vantage Solutions will present a report on our FDA pilot to “Quantify the Readiness of the VRS Network.” Join us on Monday, March 9, from 2:15-3:15 p.m., for an educational discussion about how we’re applying lessons learned from our pilot.

The deadline for meeting the Saleable Returns Verification and being able to authenticate and verify saleable returns using the VRS is November 27, so it’s crucial to be ready. See more about this below!

What to Expect at the HDA Conference

The annual gathering is HDA’s largest supply chain education event. This year, as many as 600 industry-leading manufacturers, distributors, consultants, and third parties are expected to attend the immersive “deep dive” into critical healthcare supply chain topics. But it’s not only a forum to engage in operational and strategic discussions — it’s a great networking event.

The HDA will also be presenting two prestigious awards, its Distribution Management Award (DMA) and the DMA for Industry Leadership. The DMA honors HDA member companies’ “efforts to improve the efficiency, effectiveness, and safety of the healthcare supply chain through successful trading partner initiatives that enhance processes, reduce costs, and leverage advanced technologies or logistical practices.” rfxcel won the award in 2018. The DMA for Industry Leadership recognizes an individual who has “valued and greatly enhanced trading partner relationships, contributed to the development of industry knowledge, and has actively participated within his/her company and through HDA to advance the state of the industry.”

rfxcel Is Sponsoring Must-Hear Discussions!

You won’t be able to miss us at this year’s conference. In addition to our VRS presentation with Vantage Solutions on Monday (2:15-3:15 p.m.) and our exhibit at Booth #103, we’re a sponsor of the following key supply chain discussions:

Monday, March 9

  • Intro to DSCSA
  • DSCSA Saleable Returns Verification Industry Update
  • Serialization Pilot Reports
  • Serialization Pilot Reports 2

Tuesday, March 10

  • DSCSA FDA Activity Update
  • Traceability Dispenser Panel
  • Traceability Roundtables

Get the Latest on the DSCSA VRS and rfxcel’s FDA-Approved VRS Pilot!

rfxcel is the industry thought leader in VRS. We extended the testing of VRS and have been implementing a pilot program for the FDA since June 2019 to quantify the readiness of the VRS network to meet the DSCSA Saleable Returns Requirement.

The HDA initiated the VRS with feedback from the pharma industry. It’s an automated service that verifies if a Product Identifier (PI) is valid. A PI has four components: a Global Trade Item Number (GTIN), a unique serial number, a lot ID, and an expiration date. There are multiple VRS providers, each responsible for determining if a specific group of PIs is valid. Thanks to VRS, everyone in the pharmaceutical supply chain can exchange data quickly and securely and verify a product’s validity for sale. Ultimately, this will promote the safety of patients and consumers, and ensure the authenticity of products.

Our FDA-approved pilot is structured to enable transparency and open testing. A key and unique aspect of the pilot is that we will share the details of our VRS test cases with all VRS providers to ensure they have a common detailed set of test cases. We’ll work with the providers to verify the test conditions to enable maximum readiness of the VRS network across all VRS providers. We published a draft copy of our interim findings at the HDA Traceability Seminar in Washington, D.C., in October 2019 and provided our final interim report to the FDA shortly afterwards. We’ll submit a final report to the FDA by the end of the year.

Final Thoughts

As we said above, companies have until November 27 to meet the DSCSA Saleable Returns Verification requirement and to be able to authenticate and verify saleable returns using the VRS. Through our FDA pilot and by applying our expertise in supply chain track and trace, serialization, and compliance solutions, we are helping the pharma industry prepare for this deadline.

The 2020 Distribution Management Conference and Expo is the perfect place to talk with our supply chain experts and learn everything you need to know about the VRS — as well as all the other exciting things going on at rfxcel. We’ve released the latest version of our award-winning rfxcel Traceability System (rTS 7.0). We’re continuing to blaze trails in track and trace, environmental monitoring, and worldwide compliance. And we’re growing our teams worldwide, from Russia to the Middle East to Asia. Book an appointment now (or just stop by Booth #103) and be sure to attend our VRS presentation with Vantage Solutions. We look forward to seeing you!

rfxcel Traceability System 7.0 Is Here — and We Think It’s a Game-Changer!

We’re very (very, very) excited to announce the latest version of our award-winning rfxcel Traceability System, rTS 7.0 — the complete supply chain traceability suite to secure your products.

rTS 7.0 carries on the distinguished pedigree of our signature full-stack digital supply chain solution, enabling end-to-end traceability, visibility, 24/7 environmental monitoring, and data analytics.

rTS debuted in the life sciences/pharma industry. This is where it has proven itself again and again; this is where we earned our reputation for designing supply chain solutions that go beyond the basics of “track and trace” and compliance to encompass key functionality ranging from ironclad compliance in any country to environmental monitoring that uses the latest Internet of Things (IoT) technology.

rTS 7.0 Can Optimize Supply Chains in Any Industry

We currently provide our solutions to four industries: life sciences/pharmaceuticals, food and beverage, worldwide government, and consumer goods. But one of the most exciting things about rTS 7.0 is that it can be used for supply chain management in any industry. It’s fully customizable, interoperable, and scalable, so its suite of solutions will deliver unrivaled performance no matter what your business is, what’s in your supply chain, or where your markets are. And, as always, it’s supported by rfxcel’s world-class customer support and implementation team.

rTS 7.0 also adds extra power because it’s available in a variety of languages. Our customers in Brazil, France, Germany, Japan, China, South Korea, and the Middle East appreciate that they can use every part of rTS 7.0 in their native language, ensuring faster implementation and deeper understanding of product functionalities. All the buttons, menu lists, commands, messages and notifications are clear; without language barriers, nothing stands in the way of exploiting the full potential of rTS 7.0 to meet compliance requirements and optimize every facet of supply chain operations. In other words, customers around the world can realize all the advantages of using the rTS 7.0 suite.

rTS 7.0 Means More Power

Enhanced performance and reduced processing time are just two of the major updates our customers have been anticipating. For example, rTS 7.0 dramatically reduces the time required to generate millions of serial numbers — it takes mere seconds. Some of our customers have generated billions of serial numbers over the years, and rfxcel has made certain that we can excel at meeting this need.

rTS 7.0 is the culmination of a year-long effort to make the platform more powerful and user-friendly than ever before. It has more features and capabilities that previous iterations, yet it’s intuitive and very easy to use. It centralizes complete supply chain control, can be accessed and controlled from virtually anywhere in the world, and ensures you’ll remain informed, nimble, and compliant no matter where you do business.

The main modules available in rTS 7.0 include Serialization Processing, Compliance Management, Integrated Monitoring, Raw Materials Traceability, and Data Analytics.

rTS 7.0 Marks a New Chapter in rfxcel’s 17-Year History

Another reason we’re so excited about rTS 7.0 is that it will enable us to continue our expansion into new industries, consumer goods in particular. As you may have heard, we scored major successes in consumer goods last year, especially in Russia, where we’ll be working with well-known global brands in the apparel industry. rTS will secure the supply chain for these and many other consumer goods, and ensure companies are always complying with Russia’s strict serialization regulations.

Our CEO, Glenn Abood, explains it best: “As we roll out rTS 7.0 and put it through its paces, we’ll be able to demonstrate what rfxcel brings to the table. Jack Tarkoff, our chief strategy officer, and I were compelled to start rfxcel when we realized that it was impossible for consumers to check the authenticity of their prescription drugs. We were born out of the desire to protect people from potentially harmful pharmaceutical products. Today, 17 years later, rTS 7.0 shows why we’re the best supply chain solution provider for companies in any industry.

“I also think rTS 7.0 will help us solidify our position in markets around the world. In addition to Russia, we’ve made strides in the Middle East, especially Saudi Arabia and Bahrain, and are leading in other key markets, such as Brazil.”

As Glenn said, we’re in our 17th year of developing leading-edge supply chain software solutions. With rTS 7.0, we will build on the successes we enjoyed in 2019. What were those successes? Well, in addition to making a splash in the consumer goods industry, we enhanced our powerful Integrated Monitoring (rIM) solution and MobileTraceability app, doubled the size of our team in Russia, began conducting a major pharma pilot for the U.S. Food and Drug Administration, continued leading the supply chain space in Brazil, increased our presence in the Middle East, and hosted a successful User Group in Reno, Nevada.

rTS has never been better, and we want to share our excitement with you! To learn more about what it can do for you, contact Vice President of Marketing Herb Wong at hwong@rfxcel.com or 925-824-0300 and visit rfxcel.com. And remember to bookmark our blog so you can stay up to date on everything that’s going on with rfxcel!

rfxcel Releases rTS 7.0, the Latest Version of Its Award-Winning Supply Chain Traceability Platform

February 18, 2020. rfxcel, the global leader in supply chain track and trace solutions, today announced that it will release the latest version of its rfxcel Traceability System (rTS) software platform on February 18, 2020. rTS 7.0 continues the award-winning legacy of rfxcel’s signature full-stack solution, enabling true end-to-end supply chain traceability, environmental monitoring, and analytics from anywhere in the world.

The announcement comes as the company marks its 17th year of developing leading-edge supply chain software solutions. With rTS 7.0, rfxcel anticipates building on the successes it enjoyed in 2019, which included entering the consumer goods industry, conducting major pharma pilots for the U.S. Food and Drug Administration and the Brazilian government, enhancing its powerful Integrated Monitoring (rIM) solution, launching a MobileTraceability solution, tripling the size of its team in Russia, increasing its presence in the Middle East, and hosting its annual User Group in Reno, Nevada.

rTS 7.0 can comprise up to eight discrete solutions that work in concert to harmonize, optimize, automate, and monitor virtually every aspect of supply chain operations. Though rfxcel currently provides its solutions to four industries — life sciences (pharmaceutical and medical devices), food and beverage, worldwide government, and consumer goods — the fully customizable, interoperable, and scalable nature of rTS makes it suitable for supply chain visibility and security in any industry. rTS solutions include rfxcel Integrated Monitoring for real-time cold chain traceability, Serialization Processing, Compliance Management, Raw Materials Traceability, Finished Goods Traceability, Data Analytics and Blockchain Enabler. The solutions are available in a variety of languages, which speeds implementation and boosts ease of use because people can work in their native language.

CEO Glenn Abood, who founded rfxcel in 2003 with Chief Strategy Officer Jack Tarkoff, said rTS 7.0 was the culmination of a year-long effort to make the platform more powerful and user-friendly than ever before.

“As we begin 2020 and celebrate 17 years of innovating supply chain technology and working with our customers to keep them at the forefront of their industries, we want people to know that rTS has never been better,” he said. “It has more features and capabilities than ever before, yet it’s intuitive and very easy to use. It centralizes complete supply chain control in one platform, can be accessed and controlled from virtually anywhere on Earth, and ensures companies remain informed, nimble, and compliant no matter where they do business.”

Mr. Abood added that the improved rTS 7.0 will be a boon to rfxcel as it continues its expansion into new industries and markets. “We had some major successes in the pharmaceutical industry and the government sector last year,” he said, “particularly in Russia and the Middle East, where we’ll be working with large brands and regulatory organizations. rTS 7.0 will help us solidify our position in markets around the world; in addition to Russia and the Middle East, we are leading in other key markets, such as Brazil and India.

“As we roll out rTS 7.0 and put it through its paces, we’ll be able to demonstrate what rfxcel brings to the table. Jack and I were compelled to start rfxcel when we realized that it was impossible for consumers to check the authenticity of their prescription drugs. We were born out of the desire to protect people from potentially harmful pharmaceutical products. Today, so many years later, rTS 7.0 shows why we’re one of the best supply chain traceability solution providers for companies in any industry.

rTS 7.0 will debut officially on February 18, 2020. To learn more about what it can do, contact Vice President of Marketing Herb Wong and visit rfxcel.com.

 

Herb Wong, VP of Marketing

hwong@rfxcel.com

925-824-0300

 

About rfxcel

Founded in 2003, rfxcel provides leading-edge software solutions to help companies manage every aspect of their supply chains, lower costs, and protect their products and brand reputations. Blue-chip organizations in the life sciences/pharmaceutical, food and beverage, worldwide government, and consumer goods industries trust rfxcel’s signature Traceability System (rTS) to power end-to-end supply chain solutions in key areas such as traceability, environmental monitoring, regulatory compliance, serialization, and visibility. The company is headquartered in the United States and has offices in the EU, Latin America, Russia, the Middle East, India, Japan, and the Asia-Pacific region.

Russia Serialization for Footwear

This white paper uses footwear as a case study to examine the complex Russian serialization regulations for the consumer goods industry. Starting July 1, 2019, manufacturers, importers, distributors, wholesalers, and retailers had to begin labeling their products with 2D Data Matrix codes. By February 1, 2020, footwear supply chain actors were expected to have obtained all necessary equipment (e.g., barcode scanners, printers, cash registers) and mastered the new system. Beginning March 1, 2020, production, import, and wholesale and retail sale of unmarked footwear is prohibited. Learn what you need to know to be compliant now — and always.

Russia Serialization for Pharma

This Russia serialization guide and white paper look at the massive changes coming to Russia’s supply chain, due to be completed by 2024. The transformation, designed to keep fake and substandard products out of the market, will have a huge impact on the pharmaceutical industry. For example, manufacturers and distributors must connect and comply with the National Track and Trace Digital System, Chestny ZNAK. All medications, including OTC medications, must be serialized, and there are special requirements regarding aggregation and separate serialization requirements for batches. Access this concise, easy-to-understand resource about the Russian pharma regulations.

For any other questions please reach out to our local experts:

Russia:
Victoria Kozlova
Director of Operations
Send Mail
P: +7 985 7504284

USA:
Brian Bilyeu
VP of Sales
Send Mail
P: +1 925 824 0300

Europe:
Simon Manley
Commercial Director
Send Mail
P: +44 1223 926923

Latam:
Vinicius Bagnarolli
Commercial Director
Send Mail
P: +55 11 97148 7826

India:
Arun Rao
Head of Business Development
Send Mail
P: +91 982 063 9476

Russian Pharma Compliance Update

An IQPC & rfxcel Webinar

By Mark Davison, rfxcel

THIS WEBINAR ENDED. YOU CAN ACCESS THE RECORDING BELOW.

———

Mark Davison is the Vice President of International Business for rfxcel. He is a leading traceability and digital health expert, specializing in the Internet of Things (IoT), traceability, and blockchain solutions. The author of “Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs”, Mark specializes in global health and big data issues that affect key industries such as pharmaceuticals, food/beverage, and fast-moving consumer goods (FMCG). His expertise lies heavily in serialization, supply chain security, patient safety, and government policy. He resides in the United Kingdom.

Please fill out the form below to get access to the webinar recording.